InvestorsHub Logo
Followers 6
Posts 4111
Boards Moderated 0
Alias Born 12/14/2009

Re: ignatiusrielly35 post# 71918

Thursday, 06/21/2018 11:29:05 AM

Thursday, June 21, 2018 11:29:05 AM

Post# of 108192
No, it was actually January 9, 2017 when they first mentioned seeking an EU commercialization deal. Check the Business Outlook press release.

"Pursue research, clinical and commercialization partnerships to optimize the cancer immunotherapy portfolio, including to enable development of lead asset, axalimogene filolusbac, in combination with other novel cancer therapies and to support its registration and potential commercialization in the EU."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News